|
"kuo sc"的相關文件
顯示項目 201-210 / 337 (共34頁) << < 16 17 18 19 20 21 22 23 24 25 > >> 每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2004-05 |
The Inhibitory Mechanism of YC-1, a benzyl indazole, on smooth muscle cell proliferation: an in vitro and in vivo study.
|
Wu, CH; Chang, WC; Chang, GY; Kuo, SC; Teng, CM. |
| 國立臺灣大學 |
2004-01 |
YC-1 Prevents sodium nitroprusside-mediated apoptosis in vascular smooth muscle cells.
|
Pan, SL; Guh, JH; Chang, YL; Kuo, SC; Lee, FY; Teng, CM. |
| 中國醫藥大學 |
2004 |
The inhibitory mechanism of YC-1, a benzyl indazole, on smooth muscle cell proliferation: an in vitro and in vivo study
|
Wu, CH; Chang, WC; Chang, GY; Kuo, SC; Teng, CM |
| 中國醫藥大學 |
2004 |
Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38
|
Yang, JS; Hour, MJ; Kuo, SC; Huang, LJ; Lee, MR |
| 中國醫藥大學 |
2004 |
N-ethylphenyl acetamide (EPA) inhibits DNA synthesis and n-acetylation of 2-aminofluorene in human colon tumor cells (colo 205)
|
Lin, WC; Shun, C; Huang, LJ; Kuo, SC; Yu, CS; Chung, JG |
| 中國醫藥大學 |
2004 |
The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injury
|
Peng, CY; Pan, SL; Guh, JH; Liu, YN; Chang, YL; Kuo, SC; Lee, FY; Teng, CM |
| 中國醫藥大學 |
2004 |
The blockade Ca2+ of cyclopiazonic acid-induced store-operated entry pathway by YC-1 in neutrophils
|
Wang, JP; Chen, YS; Tsai, CR; Huang, LJ; Kuo, SC |
| 中國醫藥大學 |
2004 |
Solvent effect of dimethyl sulfoxide on the chemical shifts of phenyl vinyl ketones
|
Lien, JC; Chen, SC; Huang, LJ; Kuo, SC |
| 中國醫藥大學 |
2004 |
YC-1 prevents sodium nitroprusside-mediated apoptosis in vascular smooth muscle cells
|
Pan, SL; Guh, JH; Chang, YL; Kuo, SC; Lee, FY; Teng, CM |
| 中國醫藥大學 |
2004 |
2-Benzyloxybenzaldehyde inhibits formyl peptide-stimulated increase in intracellular Ca2+ in neutrophils mainly by blocking Ca2+ entry
|
Wang, JP; Chang, LC; Kuan, YH; Tsao, LT; Huang, LJ; Kuo, SC |
顯示項目 201-210 / 337 (共34頁) << < 16 17 18 19 20 21 22 23 24 25 > >> 每頁顯示[10|25|50]項目
|